Abstract
Multidrug resistance is a major obstacle for the successful use of chemotherapy. The multidrug resistance phenotype is often attributed to overexpression of P-glycoprotein, which is an energy-dependent drug efflux pump. We investigated a new strategy to overcome multidrug resistance, using purified bovine serum amine oxidase, which generates two major toxic products from the polyamine spermine. The cytotoxicity of the aldehyde(s) and H2O2, produced by the enzymatic oxidation of micromolar concentrations of spermine, was evaluated in multidrug resistant Chinese hamster ovary cells CHRC5 with overexpression of P-glycoprotein, using a clonogenic cell survival assay. We examined the ability of hyperthermia (42 degrees C), and inhibition of cellular detoxification systems, to sensitize multidrug resistant cells to spermine oxidation products. Severe depletion of intracellular glutathione was achieved using L-buthionine sulfoximine and inhibition of glutathione S-transferase by ethacrynic acid. CH(R)C5 cells showed no resistance to the toxic oxidation products of spermine, relative to drug-sensitive AuxB1 cells. Exogenous catalase protected cells against cytotoxicity of H2O2, but spermine-derived aldehyde(s) still caused some cytotox...Continue Reading
References
Nov 15, 1978·International Journal of Cancer. Journal International Du Cancer·E Ben-HurE Riklis
Jan 1, 1976·Cancer·M H ShiuJ G Fortner
Sep 1, 1992·Bioconjugate Chemistry·H MaedaY Miyamoto
Jan 1, 1992·Critical Reviews in Biochemistry and Molecular Biology·S Tsuchida, K Sato
Jan 1, 1990·The International Journal of Biochemistry·N Seiler, F Dezeure
Apr 1, 1990·Trends in Biochemical Sciences·O Heby, L Persson
Jan 1, 1989·Annual Review of Biochemistry·J A Endicott, V Ling
Apr 1, 1987·Journal of Cellular Physiology·U BachrachA Loyter
Feb 1, 1988·Kidney International·B D MyersN S Coplon
Feb 1, 1974·Journal of Cellular Physiology·V Ling, L H Thompson
Jan 1, 1984·Annual Review of Biochemistry·C W Tabor, H Tabor
Mar 29, 1983·Biochemistry·S SuzukiT Okuyama
Jun 15, 1984·Biochemical Pharmacology·J T AhokasB T Emmerson
Sep 15, 1982·Analytical Biochemistry·P TuriniB Mondovì
Jan 1, 1995·Annual Review of Pharmacology and Toxicology·L J Marton, A E Pegg
Sep 15, 1994·Biochemical Pharmacology·E AgostinelliD A Averill-Bates
Jan 1, 1994·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·D A Averill-BatesB Mondovi
Jan 1, 1993·Archives of Biochemistry and Biophysics·D A Averill-BatesB Mondovi
Jun 6, 1997·Chemico-biological Interactions·G J Mulder, S Ouwerkerk-Mahadevan
Jan 1, 1997·Cancer Chemotherapy and Pharmacology·V Ling
Jul 24, 1998·Trends in Biotechnology·D D Lasic
Mar 9, 1999·Archives of Biochemistry and Biophysics·S Lord-Fontaine, D A Averill
Jul 28, 1999·Biochemical Pharmacology·B Larrivée, D A Averill
Nov 5, 1999·Journal of Immunotherapy·F Di FilippoR Cavaliere
Citations
Apr 22, 2015·Colloids and Surfaces. B, Biointerfaces·Ji ChengXiao Yu Wu
Apr 12, 2002·International Journal of Cancer. Journal International Du Cancer·Annarica CalcabriniEnzo Agostinelli
Oct 20, 2018·The Journal of Biological Chemistry·Tracy Murray StewartRobert A Casero
May 9, 2006·Amino Acids·E Agostinelli, N Seiler
Jul 21, 2009·Breast Cancer Research and Treatment·Qun LiuXiao Yu Wu
Dec 17, 2009·Amino Acids·E AgostinelliR Stevanato
Aug 30, 2011·Amino Acids·Paraskevi TavladorakiEnzo Agostinelli